1 / 1

Neoantigen-based Personalized Cancer therapeutic Vaccines Competitive Landscape and Market Forecast

Neoantigen-based Personalized Cancer therapeutic Vaccines are one way to utilize the bodyu2019s immune system to fight cancer. Neoantigens are highly immunogenic as they are not expressed in normal tissues. They can activate CD4 and CD8 T cells to generate immune response and have the potential to become new targets of tumor immunotherapy.<br>NSCLC possesses the maximum market share among various Neo-antigen based cancer vaccine indications in the 7 MM countries. While Brain and Bone cancer will occupy the lowest market share in the overall Neoantigen Cancer Vaccine market.<br>Some of the key companies such as OSE Immunotherapeutics, Immunitor, Gristone Oncology, Neon Therapeutics, Genocea, Targovax, Gradalis, are developing drugs for Neoantigen-based Personalized Cancer therapeutic Vaccines.<br>For more details visit: https://www.delveinsight.com/report-store/neoantigen-based-personalized-cancer-therapeutic-vaccines-competitive-landscape<br>

DelveInsight
Download Presentation

Neoantigen-based Personalized Cancer therapeutic Vaccines Competitive Landscape and Market Forecast

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

    More Related